Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

NCT02244164 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Recruitment too slow

Conditions

Type 2 Diabetes
Incretinomimetics
Pancreas

Interventions

DRUG: Incretinomimetics
DRUG: DPP-4 inhibitors

Sponsor

Erasme University Hospital